<tei xml:space="preserve">
    <teiHeader>
        <fileDesc xml:id="_0"/>
    </teiHeader>
    <text xml:lang="en">
        <listBibl>

        References<lb/> 
        <bibl><label>1</label>. <lb/> Wilczynska A, Bushell M. The complexity of miRNA-mediated repression. Cell death<lb/> and differentiation. 2015;22(1):22-33.<lb/> </bibl>
        <bibl><label>2</label>. <lb/> Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and<lb/> therapeutics. A comprehensive review. EMBO Mol Med. 2012;4(3):143-59.<lb/> </bibl>
        <bibl><label>3</label>. <lb/> Simonson B, Das S. MicroRNA Therapeutics: the Next Magic Bullet? Mini Rev Med<lb/> Chem. 2015;15(6):467-74.<lb/> </bibl>
        <bibl><label>4</label>. <lb/> Hui AB, Shi W, Boutros PC, Miller N, Pintilie M, Fyles T, et al. Robust global micro-<lb/>RNA profiling with formalin-fixed paraffin-embedded breast cancer tissues. Laboratory<lb/> investigation; a journal of technical methods and pathology. 2009;89(5):597-606.<lb/> </bibl>
        <bibl><label>5</label>. <lb/> Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, Slack F, et al. microRNA miR-<lb/>196a-2 and breast cancer: a genetic and epigenetic association study and functional<lb/> analysis. Cancer research. 2009;69(14):5970-7.<lb/> </bibl>
        <bibl><label>6</label>. <lb/> Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, et al. MicroRNA-196a<lb/> targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in<lb/> cancers. Oncogene. 2008;27(52):6667-78.<lb/> </bibl>
        <bibl><label>7</label>. <lb/> Liu XH, Lu KH, Wang KM, Sun M, Zhang EB, Yang JS, et al. MicroRNA-196a promotes<lb/> non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC<lb/> cancer. 2012;12:348.<lb/> </bibl>
        <bibl><label>8</label>. <lb/> Sun M, Liu XH, Li JH, Yang JS, Zhang EB, Yin DD, et al. MiR-196a is upregulated in<lb/> gastric cancer and promotes cell proliferation by downregulating p27(kip1). Molecular<lb/> cancer therapeutics. 2012;11(4):842-52.<lb/> </bibl>
        <bibl><label>9</label>. <lb/> Hou T, Ou J, Zhao X, Huang X, Huang Y, Zhang Y. MicroRNA-196a promotes cervical<lb/> cancer proliferation through the regulation of FOXO1 and p27(Kip1.). British journal of<lb/> cancer. 2014;110(5):1260-8.<lb/> </bibl>
        <bibl><label>10</label>. <lb/> Wang G, Wang Y, Shen C, Huang YW, Huang K, Huang TH, et al. RNA polymerase II<lb/> binding patterns reveal genomic regions involved in microRNA gene regulation. PloS<lb/> one.5(11):e13798.<lb/> </bibl>
        <bibl><label>11</label>. <lb/> Corcoran DL, Pandit KV, Gordon B, Bhattacharjee A, Kaminski N, Benos PV. Features<lb/> of mammalian microRNA promoters emerge from polymerase II chromatin<lb/> immunoprecipitation data. PloS one. 2009;4(4):e5279.<lb/> </bibl>
        <bibl><label>12</label>. <lb/> Attema JL, Bert AG, Lim YY, Kolesnikoff N, Lawrence DM, Pillman KA, et al.<lb/> Identification of an enhancer that increases miR-200b~200a~429 gene expression in breast<lb/> cancer cells. PloS one. 2013;8(9):e75517.<lb/> </bibl>
        <bibl><label>13</label>. <lb/> Punnamoottil B, Rinkwitz S, Giacomotto J, Svahn AJ, Becker TS. Motor neuron-<lb/>expressed microRNAs 218 and their enhancers are nested within introns of Slit2/3 genes.<lb/> Genesis. 2015;53(5):321-8.<lb/> </bibl>
        <bibl><label>14</label>. <lb/> Bhan A, Hussain I, Ansari KI, Kasiri S, Bashyal A, Mandal SS. Antisense Transcript Long<lb/> Noncoding RNA (lncRNA) HOTAIR is Transcriptionally Induced by Estradiol. Journal of<lb/> molecular biology. 2013.<lb/> </bibl>
        <bibl><label>15</label>. <lb/> Milevskiy MJ, Al-Ejeh F, Saunus JM, Northwood KS, Bailey PJ, Betts JA, et al. Long-<lb/>range regulators of the lncRNA HOTAIR enhance its prognostic potential in breast cancer.<lb/> Human molecular genetics. 2016;25(15):3269-83.<lb/> </bibl>
        <bibl><label>16</label>. <lb/> Ansari KI, Hussain I, Shrestha B, Kasiri S, Mandal SS. HOXC6 Is transcriptionally<lb/> regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen<lb/> environment. Journal of molecular biology. 2011;411(2):334-49.<lb/> </bibl>
        <bibl><label>17</label>. <lb/> Ansari KI, Hussain I, Kasiri S, Mandal SS. HOXC10 is overexpressed in breast cancer<lb/> and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and<lb/> MLL4. J Mol Endocrinol. 2012;48(1):61-75.<lb/> </bibl>
        <bibl><label>18</label>. <lb/> Ansari KI, Kasiri S, Hussain I, Mandal SS. Mixed lineage leukemia histone methylases<lb/> play critical roles in estrogen-mediated regulation of HOXC13. The FEBS journal.<lb/> 2009;276(24):7400-11.<lb/> </bibl>
        <bibl><label>19</label>. <lb/> Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J, et al. Common genetic variants in pre-<lb/>microRNAs were associated with increased risk of breast cancer in Chinese women. Hum<lb/> Mutat. 2009;30(1):79-84.<lb/> </bibl>
        <bibl><label>20</label>. <lb/> Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR. Single nucleotide<lb/> polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Twin Res Hum<lb/> Genet. 2011;14(5):417-21.<lb/> </bibl>
        <bibl><label>21</label>. <lb/> Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H. DNA methylation<lb/> represses transcription in vivo. Nature genetics. 1999;22(2):203-6.<lb/> </bibl>
        <bibl><label>22</label>. <lb/> Mohammed H, D&apos;Santos C, Serandour AA, Ali HR, Brown GD, Atkins A, et al.<lb/> Endogenous purification reveals GREB1 as a key estrogen receptor regulatory factor. Cell<lb/> reports. 2013;3(2):342-9.<lb/> </bibl>
        <bibl><label>23</label>. <lb/> Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. FOXA1 is a key<lb/> determinant of estrogen receptor function and endocrine response. Nat Genet.<lb/> 2011;43(1):27-33.<lb/> </bibl>
        <bibl><label>24</label>. <lb/> Magnani L, Ballantyne EB, Zhang X, Lupien M. PBX1 genomic pioneer function drives<lb/> ERalpha signaling underlying progression in breast cancer. PLoS genetics.<lb/> 2011;7(11):e1002368.<lb/> </bibl>
        <bibl><label>25</label>. <lb/> Franco HL, Nagari A, Kraus WL. TNFalpha signaling exposes latent estrogen receptor<lb/> binding sites to alter the breast cancer cell transcriptome. Molecular cell. 2015;58(1):21-34.<lb/> </bibl>
        <bibl><label>26</label>. <lb/> Millour J, Constantinidou D, Stavropoulou AV, Wilson MS, Myatt SS, Kwok JM, et al.<lb/> FOXM1 is a transcriptional target of ERalpha and has a critical role in breast cancer<lb/> endocrine sensitivity and resistance. Oncogene. 2010;29(20):2983-95.<lb/> </bibl>
        <bibl><label>27</label>. <lb/> Heimberg A, McGlinn E. Building a robust a-p axis. Curr Genomics. 2012;13(4):278-<lb/>88.<lb/> </bibl>
        <bibl><label>28</label>. <lb/> Sawado T, Halow J, Bender MA, Groudine M. The beta -globin locus control region<lb/> (LCR) functions primarily by enhancing the transition from transcription initiation to<lb/> elongation. Genes &amp; development. 2003;17(8):1009-18.<lb/> </bibl>
        <bibl><label>29</label>. <lb/> Vakoc CR, Letting DL, Gheldof N, Sawado T, Bender MA, Groudine M, et al. Proximity<lb/> among distant regulatory elements at the beta-globin locus requires GATA-1 and FOG-1.<lb/> Molecular cell. 2005;17(3):453-62.<lb/> </bibl>
        <bibl><label>30</label>. <lb/> Ko JY, Oh S, Yoo KH. Functional Enhancers As Master Regulators of Tissue-Specific<lb/> Gene Regulation and Cancer Development. Mol Cells. 2017;40(3):169-77.<lb/> </bibl>
        <bibl><label>31</label>. <lb/> Sotelo J, Esposito D, Duhagon MA, Banfield K, Mehalko J, Liao H, et al. Long-range<lb/> enhancers on 8q24 regulate c-Myc. Proceedings of the National Academy of Sciences of the<lb/> United States of America. 2010;107(7):3001-5.<lb/> </bibl>
        <bibl><label>32</label>. <lb/> Dostie J, Richmond TA, Arnaout RA, Selzer RR, Lee WL, Honan TA, et al. Chromosome<lb/> Conformation Capture Carbon Copy (5C): a massively parallel solution for mapping<lb/> interactions between genomic elements. Genome Res. 2006;16(10):1299-309.<lb/> </bibl>
        <bibl><label>33</label>. <lb/> Davies JO, Telenius JM, McGowan SJ, Roberts NA, Taylor S, Higgs DR, et al.<lb/> Multiplexed analysis of chromosome conformation at vastly improved sensitivity. Nature<lb/> methods. 2016;13(1):74-80.<lb/> </bibl>
        <bibl><label>34</label>. <lb/> Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, et al. An oestrogen-receptor-<lb/>alpha-bound human chromatin interactome. Nature. 2009;462(7269):58-64.<lb/> </bibl>
        <bibl><label>35</label>. <lb/> Jiang CF, Shi ZM, Li DM, Qian YC, Ren Y, Bai XM, et al. Estrogen-induced miR-196a<lb/> elevation promotes tumor growth and metastasis via targeting SPRED1 in breast cancer.<lb/> Molecular cancer. 2018;17(1):83.<lb/> </bibl>
        <bibl><label>36</label>. <lb/> Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, et al. A mammalian<lb/> microRNA expression atlas based on small RNA library sequencing. Cell. 2007;129(7):1401-<lb/>14.<lb/> </bibl>
        <bibl><label>37</label>. <lb/> Kron KJ, Bailey SD, Lupien M. Enhancer alterations in cancer: a source for a cell<lb/> identity crisis. Genome Med. 2014;6(9):77.<lb/> </bibl>
        <bibl><label>38</label>. <lb/> Herz HM, Hu D, Shilatifard A. Enhancer malfunction in cancer. Molecular cell.<lb/> 2014;53(6):859-66.<lb/> </bibl>
        <bibl><label>39</label>. <lb/> Chen H, Li C, Peng X, Zhou Z, Weinstein JN, Cancer Genome Atlas Research N, et al. A<lb/> Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples. Cell.<lb/> 2018;173(2):386-99 e12.<lb/> </bibl>
        <bibl><label>40</label>. <lb/> Whyte WA, Orlando DA, Hnisz D, Abraham BJ, Lin CY, Kagey MH, et al. Master<lb/> transcription factors and mediator establish super-enhancers at key cell identity genes. Cell.<lb/> 2013;153(2):307-19.<lb/> </bibl>
        <bibl><label>41</label>. <lb/> Hu Y, Zhang Z, Kashiwagi M, Yoshida T, Joshi I, Jena N, et al. Superenhancer<lb/> reprogramming drives a B-cell-epithelial transition and high-risk leukemia. Genes &amp;<lb/> development. 2016;30(17):1971-90.<lb/> </bibl>
        <bibl><label>42</label>. <lb/> Burger H. The menopausal transition--endocrinology. J Sex Med. 2008;5(10):2266-<lb/>73.<lb/> </bibl>
        <bibl><label>43</label>. <lb/> Hale GE, Robertson DM, Burger HG. The perimenopausal woman: endocrinology and<lb/> management. J Steroid Biochem Mol Biol. 2014;142:121-31.<lb/> </bibl>
        <bibl><label>44</label>. <lb/> Azim HA, Jr., Partridge AH. Biology of breast cancer in young women. Breast cancer<lb/> research : BCR. 2014;16(4):427.<lb/> </bibl>
        <bibl><label>45</label>. <lb/> Azim HA, Jr., Michiels S, Bedard PL, Singhal SK, Criscitiello C, Ignatiadis M, et al.<lb/> Elucidating prognosis and biology of breast cancer arising in young women using gene<lb/> expression profiling. Clinical cancer research : an official journal of the American Association<lb/> for Cancer Research. 2012;18(5):1341-51.<lb/> </bibl>
        <bibl><label>46</label>. <lb/> McClelland RA, Barrow D, Madden TA, Dutkowski CM, Pamment J, Knowlden JM, et<lb/> al. Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after<lb/> long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).<lb/> Endocrinology. 2001;142(7):2776-88.<lb/> </bibl>
        <bibl><label>47</label>. <lb/> Knowlden JM, Hutcheson IR, Jones HE, Madden T, Gee JM, Harper ME, et al.<lb/> Elevated levels of epidermal growth factor receptor/c-erbB2 heterodimers mediate an<lb/> autocrine growth regulatory pathway in tamoxifen-resistant MCF-7 cells. Endocrinology.<lb/> 2003;144(3):1032-44.<lb/> </bibl>
        <bibl><label>48</label>. <lb/> Staka CM, Nicholson RI, Gee JM. Acquired resistance to oestrogen deprivation: role<lb/> for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X<lb/> model. Endocrine-related cancer. 2005;12 Suppl 1:S85-97.<lb/> </bibl>
        <bibl><label>49</label>. <lb/> Miller DF, Yan PS, Buechlein A, Rodriguez BA, Yilmaz AS, Goel S, et al. A new method<lb/> for stranded whole transcriptome RNA-seq. Methods. 2013;63(2):126-34.<lb/> </bibl>
        <bibl><label>50</label>. <lb/> He DX, Gu F, Gao F, Hao JJ, Gong D, Gu XT, et al. Genome-wide profiles of<lb/> methylation, microRNAs, and gene expression in chemoresistant breast cancer. Scientific<lb/> reports. 2016;6:24706.<lb/> </bibl>
        <bibl><label>51</label>. <lb/> Gascard P, Bilenky M, Sigaroudinia M, Zhao J, Li L, Carles A, et al. Epigenetic and<lb/> transcriptional determinants of the human breast. Nat Commun. 2015;6:6351.<lb/> </bibl>
        <bibl><label>52</label>. <lb/> Welboren WJ, van Driel MA, Janssen-Megens EM, van Heeringen SJ, Sweep FC, Span<lb/> PN, et al. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding<lb/> to ligands. The EMBO journal. 2009;28(10):1418-28.<lb/> </bibl>
        <bibl><label>53</label>. <lb/> Hah N, Danko CG, Core L, Waterfall JJ, Siepel A, Lis JT, et al. A rapid, extensive, and<lb/> transient transcriptional response to estrogen signaling in breast cancer cells. Cell.<lb/> 2011;145(4):622-34.<lb/> </bibl>
        <bibl><label>54</label>. <lb/> Li G, Ruan X, Auerbach RK, Sandhu KS, Zheng M, Wang P, et al. Extensive promoter-<lb/>centered chromatin interactions provide a topological basis for transcription regulation.<lb/> Cell. 2012;148(1-2):84-98.<lb/> </bibl>
        <bibl><label>55</label>. <lb/> Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, et al.<lb/> Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.<lb/> Nature. 2012;481(7381):389-93.<lb/> </bibl>
        <bibl><label>56</label>. <lb/> Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient<lb/> alignment of short DNA sequences to the human genome. Genome biology. 2009;10(3):R25.<lb/> </bibl>
        <bibl><label>57</label>. <lb/> Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE, et al. Model-based<lb/> analysis of ChIP-Seq (MACS). Genome biology. 2008;9(9):R137.<lb/> </bibl>
        <bibl><label>58</label>. <lb/> Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al.<lb/> Integrative genomics viewer. Nature biotechnology. 2011;29(1):24-6.<lb/> </bibl>
        <bibl><label>59</label>. <lb/> Stone A, Zotenko E, Locke WJ, Korbie D, Millar EK, Pidsley R, et al. DNA methylation<lb/> of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer. Nat<lb/> Commun. 2015;6:7758.<lb/> </bibl>
        <bibl><label>60</label>. <lb/> Cancer Genome Atlas N. Comprehensive molecular portraits of human breast<lb/> tumours. Nature. 2012;490(7418):61-70.<lb/> </bibl>
        <bibl><label>61</label>. <lb/> Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic<lb/> and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature.<lb/> 2012;486(7403):346-52.<lb/> </bibl>
        <bibl><label>62</label>. <lb/> Dvinge H, Git A, Graf S, Salmon-Divon M, Curtis C, Sottoriva A, et al. The shaping and<lb/> functional consequences of the microRNA landscape in breast cancer. Nature.<lb/> 2013;497(7449):378-82.<lb/> </bibl>
        <bibl><label>63</label>. <lb/> Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of<lb/> genome-wide expression patterns. Proceedings of the National Academy of Sciences of the<lb/> United States of America. 1998;95(25):14863-8.<lb/> </bibl>
        <bibl><label>64</label>. <lb/> Hagege H, Klous P, Braem C, Splinter E, Dekker J, Cathala G, et al. Quantitative<lb/> analysis of chromosome conformation capture assays (3C-qPCR). Nature protocols.<lb/> 2007;2(7):1722-33.<lb/> </bibl>
        <bibl><label>65</label>. <lb/> Tan-Wong SM, French JD, Proudfoot NJ, Brown MA. Dynamic interactions between<lb/> the promoter and terminator regions of the mammalian BRCA1 gene. Proceedings of the<lb/> National Academy of Sciences of the United States of America. 2008;105(13):5160-5.</bibl>
        </listBibl>
    </text>
</tei>

